Author: Fiona Craig
-
Is this another 2022-style shock? JPMorgan says the comparison falls short
With oil prices climbing and geopolitical tensions rising after the U.S./Israel–Iran conflict, some investors have begun comparing the current environment to 2022 — when Russia’s invasion of Ukraine triggered an energy crisis, fueled a wage-price spiral, and led to one of the most severe market downturns in decades. But JPMorgan’s equity strategy team argues that…
-
Oil could climb to $200 if the conflict lasts through June, strategist warns
Brent crude prices could spike to as high as $200 per barrel — potentially pushing U.S. gasoline prices to roughly $7 per gallon — if the war involving Iran continues through the end of June and the Strait of Hormuz remains mostly closed to shipping, according to analysts at Macquarie. Similar concerns were voiced by…
-
Bernstein Says Crypto Stocks May Be Approaching a Bottom Despite Weak Q1 Outlook
Shares of companies tied to the cryptocurrency sector could be nearing a cyclical low, according to analysts at Bernstein, who said the recent downturn has created attractive entry points for investors. In a research note this week, the firm said geopolitical tensions combined with “temporary crypto weak sentiment is offering big discounts (~60% below 2025…
-
Goldman Sachs keeps $5,400 gold forecast despite recent pullback
Goldman Sachs continues to project that gold could reach $5,400 per troy ounce by the end of 2026, citing expected Federal Reserve interest-rate cuts, a normalization in speculative positioning, and ongoing central bank demand for bullion. The bank’s analysts Lina Thomas and Daan Struyven are maintaining that target even though gold has fallen roughly 15%…
-
DeFi Technologies appoints Jacob Lindberg as Valour CRO to drive European expansion
DeFi Technologies Inc. (NASDAQ:DEFT) said its subsidiary Valour Inc. has appointed Jacob Lindberg as Chief Revenue Officer, as the digital asset manager pushes to expand its presence across the Nordic region and broader European markets. Lindberg will lead Valour’s commercial strategy and revenue growth, focusing on expanding distribution of the company’s digital asset exchange-traded products…
-
Intel to repurchase Apollo’s stake in Irish chip facility for $14.2 billion
Intel (NASDAQ:INTC) announced it will spend $14.2 billion to repurchase the 49% stake it previously sold to Apollo Global Management in its semiconductor manufacturing facility in Ireland, restoring full ownership of the plant as its financial position improves and demand for chips rises with the growth of artificial intelligence. Shares of Intel climbed about 6%…
-
Cyclerion to combine with Korsana Biosciences in $380 million merger deal
Cyclerion Therapeutics (NASDAQ:CYCN) announced it has signed a definitive merger agreement with privately held Korsana Biosciences in an all-stock transaction, according to a company press release. The announcement comes as Cyclerion shares trade around $1.55, giving the company a market capitalization of roughly $5.9 million, with the stock down 4.3% over the past week. Following…
-
RenX reports $8.2M revenue and $15.9M net loss in first year after recycling pivot
RenX Enterprises Corp. (NASDAQ:RENX) generated $8.2 million in revenue during the seven months following its June 2 acquisition of an organic waste processing business, surpassing its previous guidance of $7.0 million by 17%, according to a company press release. For the fiscal year ended December 31, 2025, the company reported a net loss of $15.9…
-
NIO reports March deliveries of 35,486 vehicles, up 136% year over year
NIO Inc. (NYSE:NIO) announced that it delivered 35,486 vehicles in March 2026, representing a 136% increase compared with the same month last year, according to a company statement. The March total included 22,490 vehicles under the NIO brand, along with 6,877 units from the ONVO brand and 6,119 vehicles from the FIREFLY brand. During the…
-
UK regulator recommends Novo Nordisk’s Wegovy to help reduce cardiovascular risks
In a significant regulatory move, the UK’s National Institute for Health and Care Excellence (NICE) has recommended the use of Novo Nordisk’s (NYSE:NVO) Wegovy to help prevent major cardiovascular events, including heart attacks and strokes. The guidance applies to adults who are living with obesity or who are overweight, and marks the first time a…